Walter Fischli

5.4k total citations
75 papers, 4.3k citations indexed

About

Walter Fischli is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Walter Fischli has authored 75 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 37 papers in Cardiology and Cardiovascular Medicine and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Walter Fischli's work include Renin-Angiotensin System Studies (34 papers), Receptor Mechanisms and Signaling (27 papers) and Hormonal Regulation and Hypertension (17 papers). Walter Fischli is often cited by papers focused on Renin-Angiotensin System Studies (34 papers), Receptor Mechanisms and Signaling (27 papers) and Hormonal Regulation and Hypertension (17 papers). Walter Fischli collaborates with scholars based in Switzerland, United States and Netherlands. Walter Fischli's co-authors include Martine Clozel, A Goldstein, Jean‐Paul Clozel, Leroy Hood, Michael W. Hunkapiller, Thomas Weller, Patrick Hess, Christoph A. Binkert, Huda Akil and Louise I. Lowney and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Walter Fischli

75 papers receiving 4.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Walter Fischli 1.6k 1.5k 1.1k 990 627 75 4.3k
Nabil A. Elshourbagy 2.8k 1.8× 450 0.3× 1.1k 1.0× 1.2k 1.2× 373 0.6× 74 5.6k
Martine Clozel 1.7k 1.1× 3.6k 2.4× 4.2k 3.9× 339 0.3× 723 1.2× 144 8.2k
John A. Peters 2.9k 1.9× 474 0.3× 714 0.7× 1.6k 1.6× 209 0.3× 28 5.3k
Catherine Llorens‐Cortés 3.4k 2.1× 3.0k 2.0× 1.0k 1.0× 4.4k 4.4× 615 1.0× 193 9.7k
Jeanne‐Marie Lecomte 1.2k 0.8× 266 0.2× 529 0.5× 877 0.9× 295 0.5× 44 2.7k
Kaoru Yamada 1.4k 0.9× 216 0.1× 1.5k 1.4× 904 0.9× 195 0.3× 133 3.8k
J.P. Maffrand 1.3k 0.8× 922 0.6× 504 0.5× 685 0.7× 365 0.6× 56 3.9k
Robert E. Widdop 2.4k 1.5× 3.7k 2.4× 992 0.9× 693 0.7× 388 0.6× 185 6.7k
Gary L. Stiles 4.8k 3.0× 718 0.5× 904 0.8× 2.3k 2.3× 393 0.6× 122 8.1k
Karl‐Norbert Klotz 4.9k 3.1× 384 0.3× 673 0.6× 2.0k 2.0× 469 0.7× 193 9.2k

Countries citing papers authored by Walter Fischli

Since Specialization
Citations

This map shows the geographic impact of Walter Fischli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Fischli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Fischli more than expected).

Fields of papers citing papers by Walter Fischli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Fischli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Fischli. The network helps show where Walter Fischli may publish in the future.

Co-authorship network of co-authors of Walter Fischli

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Fischli. A scholar is included among the top collaborators of Walter Fischli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Fischli. Walter Fischli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corminboeuf, Olivier, Corinna Grisostomi, Sylvia Richard‐Bildstein, et al.. (2010). Design and optimization of new piperidines as renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(21). 6286–6290. 15 indexed citations
2.
Corminboeuf, Olivier, Corinna Grisostomi, Sylvia Richard‐Bildstein, et al.. (2010). Piperidine-based renin inhibitors: Upper chain optimization. Bioorganic & Medicinal Chemistry Letters. 20(21). 6291–6296. 16 indexed citations
3.
Iglarz, Marc, Christoph A. Binkert, Keith Morrison, et al.. (2008). Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 327(3). 736–745. 260 indexed citations
4.
Brisbare‐Roch, Catherine, Jasper Dingemanse, Ralf Koberstein, et al.. (2007). Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nature Medicine. 13(2). 150–155. 452 indexed citations
5.
Boss, Christoph, Olivier Corminboeuf, Corinna Grisostomi, et al.. (2006). Achiral, Cheap, and Potent Inhibitors of Plasmepsins I, II, and IV. ChemMedChem. 1(12). 1341–1345. 43 indexed citations
6.
Boss, Christoph, Martin H. Bolli, Thomas Weller, Walter Fischli, & Martine Clozel. (2003). Bis-sulfonamides as endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(5). 951–954. 8 indexed citations
7.
Bolli, Martin H., Christoph Boss, Martine Clozel, et al.. (2003). The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(5). 955–959. 9 indexed citations
8.
Boss, Christoph, Sylvia Richard‐Bildstein, Thomas Weller, et al.. (2003). Inhibitors of the Plasmodium Falciparum Parasite Aspartic Protease Plasmepsin II As Potential Antimalarial Agents. Current Medicinal Chemistry. 10(11). 883–907. 76 indexed citations
9.
Güller, Rolf, Alfred Binggeli, Volker Breu, et al.. (1999). Piperidine-renin inhibitors compounds with improved physicochemical properties. Bioorganic & Medicinal Chemistry Letters. 9(10). 1403–1408. 52 indexed citations
10.
Vieira, Eric, Alfred Binggeli, Volker Breu, et al.. (1999). Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site. Bioorganic & Medicinal Chemistry Letters. 9(10). 1397–1402. 79 indexed citations
11.
Coassolo, Ph., et al.. (1996). Pharmacokinetics of remikiren, a potent orally active inhibitor of human renin, in rat, dog and primates. Xenobiotica. 26(3). 333–345. 9 indexed citations
12.
Döbeli, Heinz, Martin Pruschy, A. D’Arcy, et al.. (1996). Recombinant Human Renin Produced in Different Expression Systems: Biochemical Properties and 3D Structure. Protein Expression and Purification. 7(1). 81–91. 20 indexed citations
13.
Clozel, Jean‐Paul & Walter Fischli. (1993). Discovery of remikiren as the first orally active renin inhibitor.. PubMed. 43(2A). 260–2. 8 indexed citations
14.
Teerlink, John R., Martine Clozel, Walter Fischli, & Jean‐Paul Clozel. (1993). Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. Journal of the American College of Cardiology. 22(2). 615–620. 72 indexed citations
15.
Clozel, Martine, Volker Breu, Kaspar F. Burri, et al.. (1993). Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 365(6448). 759–761. 426 indexed citations
16.
Weber, Wolfgang, Walter Fischli, Erich Hochuli, E. KUPFER, & E. K. Weibel. (1991). Anantin-A peptide antagonist of the atrial natriuretic factor(ANF). I. Producing organism, fermentation, isolation and biological activity.. The Journal of Antibiotics. 44(2). 164–171. 96 indexed citations
17.
Bossé, Roger, et al.. (1990). An Angiotensin with Prolonged Action and Blood Pressure-Lowering Properties. Journal of Cardiovascular Pharmacology. 16(Supplement 4). S50–S55. 10 indexed citations
18.
Clozel, Martine, et al.. (1989). Specific binding of endothelin on human vascular smooth muscle cells in culture.. Journal of Clinical Investigation. 83(5). 1758–1761. 87 indexed citations
19.
Fischli, Walter, et al.. (1989). Human Cultured Endothelial Cells Do Secrete Endothelin-1. Journal of Cardiovascular Pharmacology. 13. S229–S229. 44 indexed citations
20.
Kozlowski, Roland Z., et al.. (1986). o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.. Journal of Pharmacology and Experimental Therapeutics. 238(3). 1084–1091. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nabil A. Elshourbagy Breakdown of academic impact, for papers by Martine Clozel Breakdown of academic impact, for papers by John A. Peters Breakdown of academic impact, for papers by Catherine Llorens‐Cortés Breakdown of academic impact, for papers by Jeanne‐Marie Lecomte Breakdown of academic impact, for papers by Kaoru Yamada Breakdown of academic impact, for papers by J.P. Maffrand Breakdown of academic impact, for papers by Robert E. Widdop Breakdown of academic impact, for papers by Gary L. Stiles Breakdown of academic impact, for papers by Karl‐Norbert Klotz
Rankless by CCL
2026